Staufen, Germany

Rainer Link


Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 110(Granted Patents)


Company Filing History:


Years Active: 1999-2005

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Rainer Link: Innovator in Pharmaceutical Compositions

Introduction

Rainer Link is a notable inventor based in Staufen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions. With a total of 4 patents to his name, Link has established himself as a key figure in pharmaceutical research and development.

Latest Patents

Among his latest patents, Rainer Link has developed pharmaceutical compositions comprising 33-epi-chloro-33-desoxy-ascomycin solid dispersions. This innovative composition includes a macrolide, such as rapamycin or ascomycin, combined with a carrier medium. His work in this area demonstrates a commitment to advancing pharmaceutical formulations that can enhance drug delivery and efficacy.

Career Highlights

Rainer Link has had a successful career at Novartis AG, where he has focused on creating effective pharmaceutical solutions. His expertise in solid dispersions has contributed to the development of new therapeutic options for patients. His work is characterized by a dedication to improving health outcomes through innovative drug formulations.

Collaborations

Throughout his career, Rainer Link has collaborated with talented professionals in the field. Notable coworkers include Patrice Guitard and Barbara Haeberlin, who have worked alongside him to advance pharmaceutical research and development.

Conclusion

Rainer Link's contributions to pharmaceutical compositions highlight his innovative spirit and dedication to improving healthcare. His patents and collaborations reflect a commitment to advancing the field of pharmaceuticals, making a lasting impact on drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…